After positive research results were presented at the American College of Rheumatology Annual Scientific Meeting earlier this month, Roche announced this week that it has filed for FDA approval of a biologics license application for its drug tocilizumab (marketed as Actemra) for the treatment of signs and symptoms of RA. As Dr. Borigini explained... Read more
After writing the other week about the depressing research related to mortality rates of RA sufferers and the link to cardiovascular problems, I was pleased to see reports of another study with more positive news for people with RA. Research presented recently at the American College of Rheumatology Annual Scientific Meeting shows that the use of... Read more
In the past five decades, the country overall has seen an upward trend in people living longer. But it seems that for all the advances in Rheumatoid Arthritis drugs and treatments, there have been no improvements in lifespan for people with RA. New research published in the journal Arthritis & Rheumatism has found that despite much... Read more
October is the beginning of flu season and medical offices, hospitals and clinics, schools and employers around the country are now offering the flu vaccine, either through the "flu shot" or a nasal-spray called LAIV (FluMist®). You might be wondering why I am writing about the flu vaccine on an RA webpage. It's because people... Read more
October 12, 2007 was World Arthritis Day and, while it has already come and gone, we think this is a great opportunity for our community members to discuss how Rheumatoid Arthritis affects their lives or the lives of a loved one. This year's theme was "Small Things Matter" and we encourage all of you to submit a SharePost describing... Read more